Category: <span>Conferences</span>

Bio Connections Australia explores drug development, early phase clinical trials, translational research and expediting Australia’s great science into commercialization. It comes at a critical time for Australia’s medical research sector. The focus of the agenda this year will be on translation and commercialization of homegrown Australian research, improving drug development and clinical trials in Australia as well as the impact of COVID-19 on the landscape.

Bellberry is proud to be silver virtual exhibitors at this year’s event with Leanne Weekes, CT:IQ Program Director attending as a speaker.

Click here to register for this event

In 2020 COSA are moving away from their tradition of focussing on one or two cancers, and featuring Quality & Safety, Implementation Science and Cardio-oncology as program themes which will provide something for everyone in their multi-disciplinary membership.

Bellberry board member Professor Ian Frazer AC will be presenting a live virtual session on Friday 13th Nov entitled ‘Cancer Immunotherapy – what have we learnt since the time of Coley?’

To register for this event visit the COSA website.

 

The International Scientific Congress is taking place next week on Wednesday 20 November. Numbers are strictly limited and there are now only a few places available! Register now to secure your place. Patient groups are reminded that fee-free places can be accessed by contacting events@bellberry.com.au

Last week at the AAHMS 5th Annual General Meeting the Academy admitted 40 new Fellows in recognition of their outstanding contributions to the health and medical research landscape in Australia. In addition, the Academy has elected two global research leaders as Corresponding Fellows.

The Australian Academy of Health and Medical Sciences also launched its first honorific award, the Jian Zhou Medal, which will be awarded annually to a rising star of Australian health and medical science. The Medal is named in honour of late Dr Jian Zhou, a talented molecular biologist and virologist, who worked with Professor Ian Frazer AC to develop and patent the technology underpinning the Gardasil and Cervarix vaccines, which protect women worldwide against viruses that cause cervical cancer.

The Medal will recognise an individual who is making a significant impact in translational medical science, primarily working in Australia. The recipient will be a postdoctoral researcher within 15 years of achieving their PhD (or equivalent first research higher degree) and nominations are welcome from all fields associated with furthering biomedical and health research, whether clinical or basic biomedical research, but must have a clear translational focus.

For more information on the Medal and how to nominate a candidate, please visit the AAHMS website.

The Annual General Meeting was a resounding success and Bellberry were proud to be in attendance as well as a Platinum sponsor of the event.

ACTA International Clinical Trials Conference in partnership with the Department of Health

More than 450 delegates gathered at the ACTA International Clinical Trials Conference, held at the ICC in Sydney from 2-5 October. The Conference has been lauded as a great success, bringing together delegates and faculty including global leaders in clinical trials, data sharing, novel trial designs, health economics and consumer involvement. The Hon. Greg Hunt MP, Minister for Health opened the Conference on Thursday 3 October, highlighting the importance of clinical trials in delivering quality care and treatment, innovation and economic value to the health care system throughout Australia, with a vision to increase access to clinical trials for people from rural and regional Australia and a focus on indigenous communities. In seven workshops and 16 conference sessions across three days, the Conference explored the underlying vision of the Australian Clinical Trials Alliance and the theme of the Conference: Better health through best evidence. BB were proud to be a silver sponsor of the event. Click here for a full round-up of the event
Jerneen Williams, EPCT Manager and Leanne Weekes, CT:IQ Program Director at the ACTA Conference

Bellberry is delighted to be both sponsoring and exhibiting at this years ACTA International Clinical Trials Conference, 2 – 5 October, Sydney.

The conference brings together Australian and international experts in the cutting-edge design and conduct of clinical trials and registry custodianship, healthcare funding, policy and regulation, health care service delivery, health information technology, health economics and patient advocacy.

The Conference theme is ACTA’s reason for being – Better Health Through Best Evidence – providing a platform for national and international stakeholders to share global advances in the development of self-improving healthcare systems.

The program will address:

Bellberry is proud to be a part of this valuable event which is integral to the advancement of clinical trials research in Australia and internationally. We look forward to seeing you there!

Find out more and register on the conference website

Bellberry along with CT:IQ is sponsoring this 2-day conference in Melbourne. Jerneen Williams, Early Phase Clinical Trials Manager at Bellberry, will be attending along with CT:IQ Programme Manager Leanne Weekes. Bio Connections Australia is an annual, national event designed to foster the growth of early phase clinical research in Australia. For more information on the conference please visit the Bio Connections website.

On Monday 20 May ACTA held their National Tribute and Awards ceremony in conjunction with International Clinical Trials Day.

“Clinical trials are vital to ensuring patients receive the best treatments and get the best outcomes. Effective and efficient treatments not only reduce suffering they can also mean less time spent receiving treatment and less money spent by the patient and the health system,” said Prof John Zalcberg, Chair of ACTA.

The winner of the 2019 Trial of the Year award was the ASPREE (ASPirin in Reducing Events in the Elderly) Trial, which looked at the efficacy of people 70 and above taking aspirin daily in preventing age-related illness including heart attack and dementia. The ASPREE study was an international, multicentre clinical trial to determine whether daily low-dose aspiring prolonged good health by preventing or delaying age-related illness such as cardiovascular disease (heart attack and stroke), dementia, depression and certain cancers in the healthy elderly. It is the largest primary prevention aspiring study ever undertaken in healthy people aged at or above 70 years and the first to weigh the benefits versus the risks.

For results of the other awards including the runners up for Trial of the Year and winner of the STiNG Award for Excellence in Trial Statistics please visit the ACTA website.

A Photo Gallery of the event day can be viewed here

 

As part of the celebrations to commemorate International Clinical Trials Day on 20 May, ACTA are holding a National Tribute and Awards Ceremony. The ceremony will honour the remarkable people who have make ground-breaking clinical trials possible and will include the ACTA Trial of the Year Award, ACTA STInG Excellence in Trial Statsistics Award and the inaugural ACTA Consumer Involvement Award.

The ceremony will be held at The Royal Children’s Hospital, Melbourne, from 8-10am and is free to attend.

Please check out the Award Ceremony flyer for further details of the event.

17 -19 March – Melbourne

This years APHA Congress will examine the changing operational environment for private hospitals. Issues such as private health insurance reform, the new National Safety and Quality Health Service Standards (National Standards) and privacy will all be discussed.

The APHA Congress will continue to feature a range of social and networking events that bring delegates and exhibitors together so there are plenty of opportunities to discuss issues with peers and industry partners.

Bellberry CEO Kylie Sproston and Operations Manager Trina O’Donnell are attending this event and look forward to seeing you there!

Brisbane 31 October – 2 November 2018

The annual AusBiotech conference has brought together Australian and international biotech leaders and stakeholders for more than three decades, creating a forum to reflect on the sector’s achievements and exchange ideas to further advance the sector’s standing both nationally and globally.

AusBiotech is dedicated to consolidating this growth, and the 2018 conference will once again present issues critical to industry. A number of the Bellberry team are attending this fatastic event and we’d be delighted to chat with you so please come and say hello if you see any of us!

Oct 10 – 12, Melbourne

The AHHMS Annual General and Scientific Meeting was this year attended by Trina O’Donnell, Bellberry Operations Manager. The event was titled ‘Collecting and using Big Data – machines, artificial intelligence, epidemiology, precision medicine & health economics’ and Professor Alan Lopez AC presented the keynote address.

Trina reported that the meeting was extremely interesting and thought provoking and covered many of the key issues that are becoming prevalent in the research industry. Further information about the meeting and the session can be found at http://www.aahms.org/events/2018-annual-events/

We look forward to seeing you in Brisbane soon for AusBiotech 2018.

21-23 August, Sydney

We’re back at ARCS again this year co-exhibiting with our colleagues from PRAXIS Australia. Come and meet the team including CEO Kylie Sproston, Operations Manager Trina O’Donnell, Quality Manager Alison Barr and our two Operations and Support Officers Sally Sims and Tess Penglis.

We’re here to answer any questions you may have about Bellberry or anything related to Human Research Ethics or just come and say hi! We look forward to seeing you all here.

Higher Education Conference

28 February  – 2 March, Canberra

Universities Australia is the national peak body representing Australia’s 39 comprehensive universities. Delivered by the sector for the sector, the Higher Education conference is the annual signature event on the Australian higher education calendar attracting more than 900 delegates.  Participants include Vice-Chancellors, Chancellors, senior university representatives, Government representatives, industry representatives, members of our research community, international education specialists, media and those with an interest in higher education.

The 2018 conference theme – Future Fundamentals – will have speakers exploring the fundamental role of universities in teaching, learning and research as they reinvent themselves in a new political, economic and technological environment. Bellberry CEO Kylie Sproston is looking forward to attending this event.

For further conference information and speaker details please visit the Universities Australia conference website

Bellberry are pleased to share with you details of PRAXIS upcoming education evening event. Come along for an evening of networking over drinks and canapes and hear from thought leaders in areas relevant to the health and medical research community.